日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/25 | 6,740 | 6,760 | 6,680 | 6,760 | +20 | +0.3% | 251,100 |
2023/01/24 | 6,780 | 6,790 | 6,680 | 6,740 | +20 | +0.3% | 372,800 |
2023/01/23 | 6,710 | 6,810 | 6,710 | 6,720 | +30 | +0.4% | 273,300 |
2023/01/20 | 6,740 | 6,770 | 6,670 | 6,690 | -90 | -1.3% | 277,200 |
2023/01/19 | 6,810 | 6,900 | 6,730 | 6,780 | -70 | -1% | 218,600 |
2023/01/18 | 6,740 | 6,880 | 6,720 | 6,850 | +190 | +2.9% | 199,100 |
2023/01/17 | 6,730 | 6,740 | 6,650 | 6,660 | -90 | -1.3% | 236,000 |
2023/01/16 | 6,720 | 6,810 | 6,720 | 6,750 | -30 | -0.4% | 154,200 |
2023/01/13 | 6,860 | 6,960 | 6,750 | 6,780 | -180 | -2.6% | 320,500 |
2023/01/12 | 7,100 | 7,110 | 6,950 | 6,960 | -110 | -1.6% | 196,100 |
2023/01/11 | 6,990 | 7,100 | 6,980 | 7,070 | +40 | +0.6% | 221,700 |
2023/01/10 | 7,120 | 7,200 | 7,030 | 7,030 | -40 | -0.6% | 198,500 |
2023/01/06 | 7,140 | 7,170 | 7,060 | 7,070 | +10 | +0.1% | 213,900 |
2023/01/05 | 7,080 | 7,110 | 6,970 | 7,060 | -100 | -1.4% | 334,700 |
2023/01/04 | 7,330 | 7,330 | 7,160 | 7,160 | -320 | -4.3% | 164,300 |
2022/12/30 | 7,560 | 7,600 | 7,440 | 7,480 | -40 | -0.5% | 149,900 |
2022/12/29 | 7,410 | 7,530 | 7,370 | 7,520 | +80 | +1.1% | 99,400 |
2022/12/28 | 7,400 | 7,460 | 7,340 | 7,440 | -50 | -0.7% | 179,200 |
2022/12/27 | 7,540 | 7,570 | 7,430 | 7,490 | +20 | +0.3% | 158,400 |
2022/12/26 | 7,540 | 7,540 | 7,400 | 7,470 | -80 | -1.1% | 100,900 |
2022/12/23 | 7,480 | 7,550 | 7,450 | 7,550 | +30 | +0.4% | 98,000 |
2022/12/22 | 7,530 | 7,550 | 7,460 | 7,520 | +30 | +0.4% | 167,400 |
2022/12/21 | 7,450 | 7,600 | 7,400 | 7,490 | +20 | +0.3% | 152,600 |
2022/12/20 | 7,670 | 7,720 | 7,420 | 7,470 | -210 | -2.7% | 248,200 |
2022/12/19 | 7,790 | 7,790 | 7,650 | 7,680 | -130 | -1.7% | 135,000 |
2022/12/16 | 7,930 | 7,930 | 7,760 | 7,810 | -190 | -2.4% | 187,800 |
2022/12/15 | 8,050 | 8,050 | 7,980 | 8,000 | -20 | -0.2% | 107,000 |
2022/12/14 | 7,990 | 8,040 | 7,940 | 8,020 | +90 | +1.1% | 153,100 |
2022/12/13 | 7,900 | 7,980 | 7,870 | 7,930 | +60 | +0.8% | 155,800 |
2022/12/12 | 7,860 | 7,910 | 7,810 | 7,870 | -30 | -0.4% | 124,200 |
2022/12/09 | 7,630 | 7,900 | 7,630 | 7,900 | +190 | +2.5% | 244,300 |
2022/12/08 | 7,830 | 7,840 | 7,640 | 7,710 | -80 | -1% | 214,800 |
2022/12/07 | 7,690 | 7,830 | 7,660 | 7,790 | +40 | +0.5% | 232,800 |
2022/12/06 | 7,740 | 7,840 | 7,700 | 7,750 | ±0 | ±0% | 207,800 |
2022/12/05 | 7,770 | 7,790 | 7,670 | 7,750 | +10 | +0.1% | 241,900 |
2022/12/02 | 7,810 | 7,810 | 7,720 | 7,740 | -140 | -1.8% | 394,700 |
2022/12/01 | 8,090 | 8,090 | 7,770 | 7,880 | -210 | -2.6% | 607,900 |
2022/11/30 | 8,220 | 8,240 | 8,060 | 8,090 | -230 | -2.8% | 526,100 |
2022/11/29 | 8,520 | 8,530 | 8,280 | 8,320 | -280 | -3.3% | 258,100 |
2022/11/28 | 8,700 | 8,770 | 8,570 | 8,600 | -190 | -2.2% | 204,100 |
2022/11/25 | 8,830 | 8,850 | 8,700 | 8,790 | +30 | +0.3% | 200,100 |
2022/11/24 | 8,780 | 8,880 | 8,700 | 8,760 | +90 | +1% | 192,100 |
2022/11/22 | 8,670 | 8,760 | 8,640 | 8,670 | +150 | +1.8% | 124,200 |
2022/11/21 | 8,620 | 8,640 | 8,490 | 8,520 | -50 | -0.6% | 80,000 |
2022/11/18 | 8,470 | 8,600 | 8,460 | 8,570 | +100 | +1.2% | 161,100 |
2022/11/17 | 8,450 | 8,570 | 8,440 | 8,470 | +60 | +0.7% | 99,400 |
2022/11/16 | 8,600 | 8,600 | 8,370 | 8,410 | -200 | -2.3% | 162,200 |
2022/11/15 | 8,630 | 8,680 | 8,550 | 8,610 | +120 | +1.4% | 177,100 |
2022/11/14 | 8,330 | 8,620 | 8,300 | 8,490 | +160 | +1.9% | 291,300 |
2022/11/11 | 8,110 | 8,540 | 8,090 | 8,330 | +410 | +5.2% | 368,100 |
451~
500
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 418,600円 | +5.9% | 0.0% | 2.96% | 9.40倍 | 1.20倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 273,800円 | +56.7% | +357.2% | 0.00% | 25.35倍 | 6.04倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サワイGHD | 197,200円 | +4.0% | +25.4% | 2.69% | 9.11倍 | 1.20倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
住友ファーマ | 60,900円 | +7.5% | - | 0.00% | - | 2.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム